Abstract
Pathogenic sequence variant in the GNAI1 gene were recently introduced as a cause of novel syndrome with a manifestation of variable developmental delay and autistic features. In our study, we report a case of monozygotic twins with severe intellectual disability and motor delay and developmental dysphasia. Both probands and their parents were examined using multi-step molecular diagnostic algorithm including whole-exome sequencing (WES), resulting in the identification of a novel, de novo pathogenic sequence variant in the GNAI1 gene, NM_002069.6:c.815 A>G, p.(Asp272Gly) in probands. Using WES we also verified the microarray findings of a familial 8q24.23q24.3 duplication and heterozygous 5q13.2 deletion, not associated with clinical symptoms in probands. Our results confirmed the role of the GNAI1 gene in the pathogenesis of syndromic neurodevelopmental disorders. They support trio- or quatro-based WES as a suitable molecular diagnostics method for the simultaneous detection of clinically relevant sequence variants and CNVs in individuals with neurodevelopmental disorders and rare diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The novel GNAI1 gene variant NM_002069.5:c.815 A>G and associated phenotypes were submitted to Leiden Open Variation Database v.3.0 (Global Variome shared LOVD) under the accession number #0000763680 (https://databases.lovd.nl/shared/variants/0000763680#00008639). The general overview for the novel GNAI1 gene variant pathogenicity is available in the VarSome database via a permanent link: varso.me/XCDS. Microarray data for probands A and B are available in the database EGA under the accession number EGAD00001007742, WES data for probands A and B and their parents are available in the database EGA under the accession number EGAD00001007736. Sanger sequencing data, including the chromatograms of the probands and the parents for the GNAI1 pathogenic variant, and the MLPA outputs for 5q13.2 deletion are stored in the Figshare online digital repository (doi.org/10.6084/m9.figshare.14401019 and doi.org/10.6084/m9.figshare.14423438).
The outputs of predictor pathogenicity tools for the GNAI1 pathogenic variant are stored in the Figshare online digital repository (doi.org/10.6084/m9.figshare.14401697). The other supporting data (qPCR analysis and other pathogenicity predictors) are available from the corresponding author on the reasonable request.
Supplementary information is available at Journal of Human Genetics’s website.
References
Kochinke K, Zweier C, Nijhof B, Fenckova M, Cizek P, Honti F, et al. “Systematic phenomics analysis deconvolutes genes mutated in intellectual disability into biologically coherent modules”. Am J Hum Genet 2016;98:149–64.
Abrahams BS, Arking DE, Campbell DB, Mefford HC, Morrow EM, Weiss LA, et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders. Mol Autism 2013;4:36.
Pereanu W, Larsen EC, Das I, Estévez MA, Sarkar AA, Spring-Pearson S, et al. AutDB: a platform to decode the genetic architecture of autism. Nucleic Acids Res 2018;46:D1049–54.
Bosch DE, Willard FS, Ramanujam R, Kimple AJ, Willard MD, Naqvi NI, et al. A P-loop mutation in Gα subunits prevents transition to the active state: implications for G-protein signalling in fungal pathogenesis. PLoS Pathog 2012;8:e1002553.
Soundararajan M, Willard FS, Kimple AJ, Turnbull AP, Ball LJ, Schoch GA, et al. Proc Natl Acad Sci USA 2008;105:6457–62.
Hamada N, Iwamoto I, Kawamura N, Nagata K-I. Heterotrimeric G-protein, Gi1, is involved in the regulation of proliferation, neuronal migration, and dendrite morphology during cortical development in vivo. J Neurochem 2021;154:1167–81.
Hunt TW, Ta Fields, Casey PJ, Peralta EG. RGS10 is a selective activator of G alpha i GTPase activity. Nature 1996;383:175–7.
Ogden SK, Fei DL, Schiling NS, Ahmed YF, Hwa J, Robbins DJ. G protein Galphai functions immediately downstream of Smoothened in Hedgehog signalling. Nature 2008;456:967–70.
Kotak S, Busso C, Gönczy P. Cortical dynein is critical for proper spindle positioning in human cells. J Cell Biol 2012;199:97–110.
Kiomytsu T, Cheeseman IM. Chromosome- and spindle-pole-derived signals generate an intristic code for spindle position and orientation. Nat Cell Biol 2012;14:311–7.
Betke KM, Wells CA, Hamm HE. GPCR mediated regulation of synaptic transmission. Prog Neurobiol 2012;96:304–21.
Muir AM, Gardner JF, van Jaarsveld RH, de Lange IM, van der Smagt JJ, Wilson GN, et al. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia. Genet Med 2021;23:881–7.
O’Hayre M, Vázquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, et al. The Emerging mutational landscape of G-proteins and G-protein coupled receptors in cancer. Nat Rev Cancer 2013;13:412–4.
Silva M, de Leeuw N, Mann K, Schuring-Blom H, Morgan S, Giardino D, et al. European guidelines for constitutional cytogenomic analysis. Eur J Hum Genet 2019;27:1–16.
Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 2016;44:D862–8.
Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics 2019;35:1978–80.
Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 2005;33:D514–17. Database issue.
Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am J Hum Genet 2009;84:524–33.
Adzhubei I, Jordan DM, Sunyaev S. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013;0:7. Unit7.20.
Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015;31:2745–7.
Stephenson JD, Laskowski RA, Nightingale A, Hurles ME, Thornton JM. VarMap: a web tool for mapping genomic coordinates to protein sequence and structure and retrieving protein structural annotations. Bioinformatics 2019;35:4854–6.
Steinhaus R, Proft S, Schuelke M, Cooper DN, Schwarz JM, Seelow D. MutationTaster2021. Nucleic Acids Res 2021;49:W446–W451.
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1–1.30.33.
Pineda VV, Athos JI, Wang H, Celver J, Ippolito D, Boulay G, et al. Removal of Giα1 constraints on adenylyl cyclase in the hippocampus enhances LTP and impairs memory formation. Neuron. 2004;41:153–63.
Yang G, Shcheglovitov A. Probing disrupted neurodevelopment in autism using human stem-cell derived neurons and organoids: An outlook into future diagnostics and drug development. Dev Dyn 2020;249:6–33.
Turner TN, Hormozdiari F, Duyzend MH, McClymont SA, Hook PW, Iossifov I, et al. Genome sequencing of autism-affected families reveals disruption of putative noncoding regulatory DNA. Am J Hum Genet 2016;98:58–74.
Coe BP, Stessman HAF, Sulovari A, Geisheker MR, Bakken TE, Lake AM, et al. Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity. Nat Genet 2019;51:106–16.
Satterstrom FK, Kosmicki JA, Wang J, Breen MS, De Rubeis S, An J-Y, et al. Large-Scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell 2020;180:568–584.e23.
Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;542:433–38.
Kaplanis J, Samocha KE, Wiel L, Zhang Z, Arvai KJ, Eberhardt RY, et al. Evidence for 28 genetic disorders discovered by combining healthcare and research data. Nature 2020;586:757–62.
Soukupova J, Pohlreich P, Seemanova E. Characterization of ATM mutations in Slavic Ataxia telangiectasia patients. Neuromolecular Med 2011;13:204–11.
Broeks A, Urbanus JHM, Floore AN, Dahler EC, Klijn JGM, Rutgers EJT, et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 2000;66:494–500.
Choi M, Kipps T, Kurzrock R. ATM mutations in cancer: therapeutic implications. Mol Cancer Ther 2016;15:1781–91.
Koch M, Schulze J, Hansen U, Ashwodt T, Keene DR, Brunken WJ, et al. A novel marker of tissue junctions, collagen XXII. J Biol Chem 2004;279:22514–21.
Eggermann K, Gläser D, Abicht A, Wirth B. Spinal muscular atrophy (SMA): best practice of diagnostics, newborn screening and therapy. Med Genet. 2020;32:263–72.
Wayhelova M, Oppelt J, Smetana J, Hladilkova E, filkova H, Makaturova E, et al. Novel de novo frameshift variant in the ASXL3 gene in a child with microcephaly and global developmental delay. Mol Med Rep. 2019;20:505–12.
Wayhelova M, Ryzi M, Oppelt J, Hladilkova E, Vallova V, Krskova L, et al. Novel familial IQSEC2 pathogenic sequence variant associated with neurodevelopmental disorders and epilepsy. Neurogenetics 2020;21:269–78.
Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities ot congenital abnormalities. Am J Hum Genet 2010;86:749–64.
Gao C, Wang Y, Mei S, Li D, Duan J, Zhang P, et al. Diagnostic yields of trio-WES accompanied by CNVSeq for rare neurodevelopmental disorders. Front Genet 2019;10:485.
Acknowledgements
The authors are thankful to the family for its participation, and all physicians and medical staff providing the specialized medical examinations supporting and completing the diagnosis of our patients.
Funding
This work was supported by Ministry of Health of the Czech Republic, grant nr. NU20-07-00145. All rights reserved.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. MW and VV analysed and interpreted the WES data regarding the probands’ phenotypes using relevant literature, databases and in silico tools. MW was a major contributor in writing the manuscript. PB processed raw WES data using advanced bioinformatics tools through in-house developed pipeline for SNV and indel calling and variant annotation. PB and AM performed CNV calling from processed WES data. DL, VV and JS performed and interpreted microarray analysis. MW and HF performed qPCR, Sanger sequencing and MLPA verification analyses. KD and RG provided specialized genetic counselling for the probands and their family and interpreted the laboratory findings in the clinical context. PK contributed towards the interpretation of data and performed general scientific supervision and general critical revision of the manuscript. All authors discussed the results, reviewed and approved the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval and consent to participate
All procedures performer involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval was obtained from the Research Ethics Committee of Masaryk University (reference number EKV-2019-056) and Ethics Committee of University Hospital Brno (10-120619/EK). Written informed consent was obtained from the parents of the patients before the procedure of genetic analyses. This case report does not include any personal information leading to the identification of any participants. The consent for publication was obtained in the scope of informed consent.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Wayhelova, M., Vallova, V., Broz, P. et al. Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development. J Hum Genet 67, 209–214 (2022). https://doi.org/10.1038/s10038-021-00988-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-021-00988-w
This article is cited by
-
Exome sequencing improves the molecular diagnostics of paediatric unexplained neurodevelopmental disorders
Orphanet Journal of Rare Diseases (2024)